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Abstract
Although palliative care is designed to provide holistic comfort care and support, sev-
eral patients still experience loss of purpose in life, and suffer from distress, sadness, 
anxiety, or decreased quality of life (QoL). To address these unmet needs, novel inter-
ventions, focused on psychosocial sources of distress, in hospice patients are needed. 
One such intervention is dignity therapy (DT), defined as a brief, individualized psy-
chotherapy, applied for the purpose of relieving psychological distress at the end of 
life. “Calendarium Vitae” (CV) as a form of DT represents a feasible, safe, and effective, 
patient-friendly approach, targeting end-of-life psychological issues. In particular, DT 
can alleviate suffering and distress, help preserve psychophysical integrity, and sup-
port caregivers, during the bereavement period. This pilot study is designed to collect 
preliminary data, prior to conducting a larger randomized controlled trial (RCT) that 
will investigate the correlations of DT intervention with QoL, and possible reduction of 
distress and suffering, in the Eastern and Central European hospice patients (and their 
caregivers). Since DT is unknown in this part of Europe, the proposed pilot study, fol-
lowed by RCT, will be the first step on the way to explore the DT intervention in research, 
among the vulnerable hospice patient population.
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1. Introduction
1.1. Scientific aim of the project
Background: Despite enormous progress that has been made in reducing the morbidity and 
mortality from a variety of neoplastic diseases, a large number of cancer patients progress to 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
advanced stages of malignancy. Such patients are usually referred for palliative care services, 
and if their prognosis is estimated to be less than 6 months, they are often admitted to the 
hospice setting [1]. In case of an incurable metastatic cancer, in addition to multiple disease-
related physical symptoms, many of such patients painfully experience loss of purpose in life 
and severe distress [2]. Although palliative care is designed to provide holistic comfort care, 
spiritual and psychosocial support until the end of life (and also during bereavement, for fam-
ily members), several hospice patients still suffer from psychological distress and decreased 
quality of life (QoL).
To fulfill these unmet needs, novel interventions, able to directly address psychosocial 
sources of distress, among the hospice patients are needed [3–5]. One such intervention is 
dignity therapy (DT), defined as a brief, individualized psychotherapy, applied for the pur-
pose of relieving psychological distress at the end of life [6]. Based on scientific evidence from 
published research in this field, derived from international studies, DT has been shown to 
be a feasible and effective novel strategy that targets psychophysical suffering in terminally 
ill patients [7]. In particular, DT attempts to help such patients reflect upon issues that are 
most meaningful to them, and document them in form of the “final document” [8]. However, 
DT is unknown in Eastern and Central Europe, and thus should be explored among hospice 
patients in these countries.
1.2. The study hypothesis
The study hypothesis is that the proposed pilot study will gather necessary information to cre-
ate a foundation for a further randomized controlled trial (RCT) that will explore the correla-
tions (or impact) of dignity therapy (DT) intervention with quality of life (QoL), and possible 
reduction of distress and suffering, among the hospice patients in Eastern and Central Europe.
It is expected that the patients in the DT intervention group (study group, SG) might have 
improved QoL, compared to the control group (CG), receiving a standard palliative care 
only. In addition, the caregivers of patients in the DT intervention group (SG) may also have 
improved QoL and psychophysical health condition during bereavement, compared to the 
control group (CG).
2. Psychophysical and social importance of the study theme
2.1. State of the art relevant to knowledge on dignity therapy (DT) intervention 
in  hospice setting
In many palliative care programs, a significant progress in pain management and symptom-
atic control has been accomplished among patients with terminal stages of metastatic cancer. 
However, despite these advances, dignity-related issues, including loss of personal auton-
omy and sense of purpose in life, or feeling a burden to family represent common causes 
of spiritual suffering, psychological distress (e.g., anxiety and depression), and decreased 
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quality of life (QoL) among hospice patients. To respond to this challenge, innovative strate-
gies are necessary. One such exemplary intervention is called dignity therapy (DT) [9]. DT 
is a psychotherapeutic intervention that was developed by Prof. Chochinov and colleagues, 
in 2012, in Canada. The main goal of DT is to decrease emotional and spiritual suffering, 
enhance quality of life, and increase a sense of meaning and purpose of life among termi-
nally ill patients near death. In particular, DT attempts to help such patients reflect upon 
things that are most meaningful to them, and collect these memories in form of the “final 
document” [9].
Dignity therapy question protocol (DTQP) is a set of standard questions that a therapist asks 
during an interview (conveniently conducted at the bedside) with the patient [10]. Evidence 
from recent research studies (conducted in Canada, Australia, and the USA) has revealed 
significant reduction of sense of suffering, depressed mood, and improvement in sense of 
dignity among terminally ill patients [11]. In summary, DT was found to be satisfactory 
to the patients, helpful to their relatives during grief period, and acceptable to the hospice 
personnel (e.g., better relations with patients and increased job satisfaction were reported) 
[12, 13].
2.2. Justification of the study theme
The proposed novel pilot study is going to explore the correlations between the perceived 
distress (anxiety, sadness, and depression) and emotional suffering (related to terminal stages 
of cancer), and DT intervention (in form of the Calendarium Vitae, CV) in hospice patients.
An analysis of the data from this pilot study is going to answer the following research 
questions:
1. Is the DT intervention (used in the design of this study) feasible for the local hospice 
system?
2. In which way the study should be adapted to the local hospice setting?
3. Can this study estimate some effects in the area of psychological distress, and in quality of 
life (QoL) that are expected to happen in relation with the DT intervention?
4. Can this study assess the effects on psychophysical health of the caregivers (e.g., family 
members) of the hospice patients that are expected to happen with the DT intervention?
2.3. Justification of the innovative character of the study
Although many hospice patients suffer from psychological distress (anxiety and depression), 
they are usually not aware of potential benefits of the DT intervention. According to the sci-
entific literature, implementation of DT, as one of the components of comprehensive pallia-
tive care, represents a manageable therapeutic approach to hospice population that might, 
to some extent, improve coping with end of life psychosocial distress, and alleviate mental 
and spiritual suffering. Therefore, DT—as an innovative, simple, safe, patient-friendly, and 
“Calendarium Vitae” for Hospice Patients and their Caregivers: A Pilot Study
http://dx.doi.org/10.5772/intechopen.70190
111
cost-effective option to fulfill unmet needs among growing population of hospice patients—
deserves an analysis in research. Moreover, it can be expected that in the future, depend-
ing on the preliminary study results, a possible implementation of DT, as a supportive care 
option, added to standard palliative care, could bring some beneficial effects for many suffer-
ing patients at the end-of-life stage in Eastern and Central European countries.
2.4. The importance of the study results for the development of scientific discipline 
and  civilizational progress
The results of the proposed project (as evidenced in a recent, substantial body of scientific 
literature in this field) will have a significant impact on the development of several scientific 
disciplines, such as psycho-oncology, psychology, medicine, nursing, rehabilitation, peda-
gogy, humanistic, or social sciences, as well as general civilizational progress, civilizational 
progress oriented on universal human values.
In addition, research infrastructure, created in this study, will provide a unique oppor-
tunity for education and training of students and postgraduates in psycho-oncology and 
related disciplines. Moreover, the project will create a support network and educational 
center for caregivers (“care for the caregivers”), hospice personnel and volunteers, as well 
as students or postgraduates, working on their MS degrees in the above-mentioned medi-
cal, psychological, social, pedagogical, or other disciplines related to the health care. On the 
basis of the above facts, exploring DT intervention as a potential component of multidisci-
plinary palliative care is justified in the hospice setting and merits support. In conclusion, 
research studies (both pilot and RCT) investigating various aspects of DT (in form of the 
CV intervention) should have a chance of being conducted in hospice patients in Eastern 
and Central Europe.
3. The main concept and aims of the pilot study
3.1. Dignity therapy: a concept of the study
A concept of the study is dignity therapy (DT), which has international scientific recognition 
(as safe and effective supportive therapy), but is unknown in Eastern and Central Europe and 
should be explored in research (e.g., first in a pilot study and then in RCT) among hospice 
patients in Eastern and Central European countries.
The pilot study will collect preliminary data, prior to conducting a larger randomized con-
trolled trial (RCT) that will investigate the correlations (impact) of dignity therapy (DT) 
intervention with quality of life (QoL), and possible reduction of distress and suffering in 
the Eastern and Central European hospice patients. Also, for caregivers of the study patients, 
the effects of DT intervention, in relation to their psychophysical health condition, during 
bereavement will be explored. Simultaneously, the caregivers will be asked to provide their 
opinions about the DT intervention.
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For the purpose of this study, a form of DT intervention, which is also called “Calendarium 
Vitae” (CV), involves both patients and (whenever possible) caregivers (participating as 
a team: patient and caregiver). The patients will be asked questions about their most 
important achievements, roles, and other important aspects of their life. In addition, CV 
intervention encourages patients to saying things to their loved ones that have remained 
unsaid. At the same time, CV invites the caregivers to contribute to the creation of the DT 
final document (CV album) that will be a “treasure” for the family and friends during 
bereavement.
3.2. The primary aims of this pilot study
The primary aims of this pilot study are as follows:
• Test feasibility of the dignity therapy (DT) before conducting a larger randomized clinical 
trial (RCT) among hospice patients in Eastern and Central European countries.
• Adapt the DT intervention to local health care circumstances (Eastern and Central Euro-
pean hospice patients).
• Learn the caregiver perspectives with regard to the benefits and possible concerns of DT 
intervention, when provided as a therapeutic procedure, added to palliative care.
3.3. The particular goals of RCT
The particular goals of RCT are as follows:
• To examine whether the addition of dignity therapy (DT) in form of the Calendarium Vi-
tae (CV) to standard palliative care (PC) could reduce psychological distress (anxiety and 
depression) and augment quality of life among the hospice patients (Pts) in Eastern and 
Central European countries.
• To test whether the addition of the CV intervention (to standard PC for the patients) could 
influence their caregiver’s psychophysical health.
• To conduct a follow-up assessment of the caregiver psychophysical health (post 6–12 
months).
These findings will be compared to the results of the control group receiving standard PC.
3.4. A possible adaptation of the pilot study into Eastern and Central European hospice 
setting: initial plan of the study
It is estimated that in this study, a total of about 100 patients diagnosed with an advanced neo-
plastic disease and poor prognosis (life expectancy < 6 months), who receive palliative care in 
the hospice, will be randomly assigned to either DT (CV) or PC in a 1:1 ratio. Patients will be 
prescreened and included to the study, if they report increased psychological distress (anxiety 
or depression, based on the Hospital Anxiety and Depression Scale (HADS)).
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The therapy will be guided by therapists (working in teams with postgraduate students). CV 
consists of three tape-recorded + one final sessions. The main goal of the CV intervention is to 
invite patients to reflect on their most important accomplishments, roles in their lives, or other 
things that they would most want to be remembered. Upon completion of the intervention, 
the recorded sessions will be transcribed and edited to provide a clear narrative CV document 
(album) that can be given to a person selected by the patient (e.g., family member, friend), or 
donated to hospice (as an option). The proposed CV intervention, in addition to the original 
DT model, introduces a patient-caregiver “team” approach in which both the patient and the 
caregiver (usually a close family member) actively participate in creation of the final DT docu-
ment (CV album) (e.g., the patient is mostly involved with the 1st, “conceptual” part, and the 
caregiver is helping with the 2nd “executive” part, by “gathering evidence” (such as photos, 
for the CV album).
4. Study methodology
4.1. Methodology and implementation of the pilot study
Study design RCT: Interventional, experimental, prospective, randomized, controlled, paral-
lel, with a follow-up (6–12 months).
Study group (SG): Hospice patients (with caregivers, women, and men, aged >18, with pre-
served cognitive skills, diagnosed with advanced cancer, with life expectancy <6 months), 
receiving palliative care at the stationary or home hospice setting, plus DT. Control group 
(CG) (similar in size to the SG), hospice patients (as in SG), receiving standard palliative care 
at the stationary or home hospice setting.
4.1.1. Study intervention
Calendarium Vitae (CV), as a form of DT, involves patients and caregivers (as teams) asking 
the patients questions about their most important achievements, roles, and other important 
aspects of life. Simultaneously, CV invites the caregivers to contributing to the creation of the 
DT final document (CV album).
4.1.2. Eligibility criteria
Inclusion criteria for patients (Pts):
• Signed informed consent form
• Diagnosis of advanced cancer, with life expectancy < 6 months
• Receiving palliative care at the hospice (stationary or home)
• ≥18 years of age
• Preserved cognitive skills
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Exclusion criteria for patients (Pts):
• Cognitive impairment (e.g., dementia, delirium)
• Deterioration of illness precluding further participation in the study
Inclusion criteria for caregivers:
• Signed informed consent form
• Taking care of a close relative admitted to hospice (stationary or home), with life expec-
tancy < 6 months
• ≥18 years of age
• A desire to alleviate suffering and distress of the terminally ill relative, beyond standard 
care
Exclusion criteria for caregivers:
• Physical or mental illness precluding participation in the study
4.1.3. Study outcome measures (OM) and tools
Outcome measures for hospice patients (Pts):
1. Psychological distress: measured by the Hospital Anxiety and Depression Scale (HADS)
2. Health related quality of life: (HRQol)
(Time frame: Pre-postintervention (when the final study document = CV album is received by 
the patient, and again 2 weeks later)
Outcome measures for caregivers:
1. Psychophysical condition: measured by General Health Questionnaire (GHQ 12) and Pa-
tient Health Questionnaire (PHQ 9)
2. Brief survey presenting caregivers’ opinions about the benefits and possible concerns rel-
evant to the dignity therapy (in form of the CV), added to standard PC
(Time frame: 1, pre-postintervention, and again 2 weeks later; 2, with the last evaluation)
The main study procedures:
Orientation meeting for the study therapists, investigators, coordinators, hospice staff, and 
caregivers. CV intervention includes four sessions:
1. introduction (60');
2. intake session (60');
3. editing session (60');
4. final session (60')
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(each session could be extended to 2 hours, depending on the patient’s condition)
All sessions will be conducted by a team, including a therapist (e.g., a psychologist, or a phy-
sician) and a student (a graduate student preparing MS thesis, or a specially trained hospice 
volunteer (optional))
All therapy sessions will be tape-recorded, transcribed, edited by the team and returned to 
the patient and the caregiver.
Construction and editing of the CV album requires a brief training session for the team mem-
bers (to assure quality of care and to avoid bias)
Total duration of pilot study: 2 weeks (intervention) + 3 months follow-up.
Total duration of RCT: 2 weeks (intervention) + 6, 12 months follow-up.
Statistical analysis: descriptive statistics.
Equipment: laptops, dictaphones, paper, pens, pencils, graphic, and printing services.
4.2. Detailed description of the study operationalization: logistics of the study
4.2.1. Setting
This study will be conducted in Eastern and Central European hospice setting. Therapists 
(such as psychologists or physicians in collaboration with MS students, forming teams) who 
are interested and eligible to participate in the study and who are professionally involved 
with palliative care (PC) hospice settings will be invited to participate. It is estimated that the 
number of therapist-investigators should be approximately 2–4.
4.2.2. Investigators
Before initiation of the program, each team will receive an individual training with regard to 
the study design, procedures, and methodology, as described in the study protocol. In addi-
tion, every therapist-investigator will be trained in DT, in order to conduct the DT intervention.
4.2.3. Participants
Adult patients with terminal stage of cancer (<6 months prognosis) who are referred by their 
attending physicians (oncologists or family physicians) for palliative care (PC) hospice ser-
vice and who express their interest in participation in the study will be invited as candidates, 
shortly after admission to hospice within the study recruitment period. The participants 
will be recruited from adult oncology patients, discharged from the University Hospitals or 
Oncology Centers.
4.2.4. Recruitment
Information about the study, together with an invitation to participate in it, will be conveyed 
to potential candidates, during routine hospice visits via flyers, posters, and also through 
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advertisements in local newspapers, and via the Internet. Interested patients (and their care-
givers) will receive detailed information regarding the DT course and will be screened (with 
the HADS). First-inclusion and exclusion criteria will be checked in a standardized interview, 
and then the patients (and the caregivers) will have a brief introduction conducted by the 
study investigator or coordinator.
It is estimated that the number of participants screened for the study should be approximately 
100, in order to enroll into the study about 10–20 patients with terminal cancer, for the study 
group (SG), and about 10–20 patients, for the control group (CG). Eligible candidates will sign 
an ICF (after explanations about the study principles and voluntary participation in it) and 
will be enrolled into the study, which will be commenced in the year 2017.
4.2.5. Study groups
In 2017, about 100 adult patients, who suffer from terminal cancer (diagnosed at least 3 
months prior to entering of the pilot study) will be randomized to a study group or control 
group.
The study group (SG) (N = 10–20) will be composed of women and men with terminal cancer, 
with <6 months prognosis, aged >18 years, treated with a standard palliative care will receive 
DT intervention.
The control group (CG) (similar in size, age, diagnosis, and prognosis to the SG) will be com-
posed of hospice patients and will receive a standard palliative care (PC) only.
Duration of the study DT intervention equals to 2 weeks, and includes: 2-week DT process, 
with 4 bi-weekly sessions (the study intervention = Calendarium Vitae, CV).
The patients in the SG will be obligated to:
• participation in the DT sessions; and
• filling out research questionnaires.
The patients in the CG will be receiving PC only, and filling out research questionnaires.
The pilot study participants in both groups will continue their regular, standard PC.
4.2.6. Management of randomized controlled trial (RCT) examining DT intervention among 
hospice  patients.
After completing of the pilot study, a subsequent step of recruitment of the volunteers-
participants for the RCT (DT in hospice patients) will be conducted according to the same 
design, by therapists-investigators in the year 2017, and continued for the consecutive 
steps of the project.
As in the pilot study, during the above-mentioned recruitment periods, the therapists-
investigators will invite to take part in this trial, a larger number of patients with terminal 
cancer admitted to hospice care facility. Adult men and women (>18 years of age) with 
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terminal cancer and <6 months prognosis, who are interested in participation in the trial 
will be given information about the study, upon admission to hospice, within the trial 
recruitment phase.
In the process of recruiting the hospice patients-volunteers to RCT (including distribution of 
the trial information and pre-screening via the standardized interview and HADS), the same 
methodology as in the pilot study will be used.
It is estimated that the number of participants screened for the RCT should be approximately 
500, in order to enroll into the trial about 50–100 patients with terminal cancer for the study 
group (SG) and 50–100 patients with terminal cancer for the control group (CG).
Eligible candidates, who meet the Inclusion/exclusion criteria, will sign an ICF (after explana-
tions about the trial principles, and voluntary participation in it), and will be enrolled into 
the trial, which will start in the year 2018. The trial will use the same procedures (including 
randomization), eligibility criteria, psychometric measurements, and outcome measures, as 
the pilot study. In 2019, a follow-up of this trial will be conducted using the same outcome 
measures as the ones used in the pilot study.
4.2.7. Inclusion/exclusion criteria: (pilot study and trial (RCT))
Eligibility criteria: Inclusion/exclusion for participants (as previously listed)
Based on:
• screening interview,
• meeting of the inclusion criteria (all the responses are Yes),
• meeting of the exclusion criteria (all the responses are No), and
• signing a voluntary informed consent form (ICF),
patients who meet qualification criteria will be enrolled into the pilot study/RCT.
The data derived from the study participants will be summarized and then utilized in statisti-
cal analyses. Pilot study parameters, which will be analyzed, according to the questionnaire, 
prepared for the purpose of this study, will contain the following variables:
1. The participant’s identification number (for confidentiality purposes)
2. Date of birth (age)
3. Gender
4. Education (higher, medium, or elementary level)
5. Place of residence (country, town)
6. Type of the cancer
7. Duration of the oncological therapy—how many years?
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8. State of health prior to a diagnosis of cancer
9. Presence of serious/chronic diseases—what kind?
With regard to caregivers of the study patients, the analogical questionnaire (with modifica-
tion of items 6–9) will be used as follows:
1. The caregiver’s identification number (for confidentiality purposes)
2. Date of birth (age)
3. Gender
4. Education (higher, medium, or elementary level)
5. Place of residence (country, town)
6. Type of the cancer of the relative admitted to hospice care
7. Duration of to taking care of the relative with terminal cancer—how many years?
8. State of health prior to taking care of a relative with terminal cancer, admitted to hospice 
9. Presence of preexisting serious/chronic diseases—what kind?
The electronic database will be created using software program, and analyses of variables will 
be performed, utilizing the statistical program. Decisions regarding exclusion of the records 
from the statistical analyses will be made in the case of:
1. lack of the complete answers in the questionnaire form;
2. illegible or ambiguous record in the questionnaire, precluding proper evaluation of vari-
ables in statistical analyses;
3. lack of written signature of the study/trial participant (informed consent form); and
4. documented information of the therapist-investigator regarding further participation in 
the study.
Psychometric measurements will be taken on the day of initial survey completion, and then 
post-DT intervention, and again, one 2 weeks after it. The study teams will collect the data 
using the study clinical report forms (CRF), based on the patients’ questionnaires and psycho-
metric measurements obtained during the study visits.
DT intervention (described in detail in another section) will be offered in one hospice center 
and will consists of a 1–2 hour sessions, 2 times per week (for 2 weeks), during which, the 
participants will complete the DT final document = CV album (including “life reflection inter-
view” that will be transcribed and revised, before final edition of the CV album). The primary 
focus of the DT is to have a positive reflection on life, leading to decreased psychophysical 
distress and suffering that should translate into better QoL. Similarly, for the caregivers, the 
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main focus of the DT is to be able to better cope with stress and suffering, related to terminal 
disease of the relative.
4.2.8. Study timeline
Schedule of the research visits.
V# 1—Orientation/introduction (0 week),
V# 2—Intake/interview (1 week),
V# 3—Revision/edition (2 weeks),
V# 4—Final (3 weeks).
Abbreviations used in the schedule: V—visit.
From a practical point of view, the pilot study and RCT will analyze the measured psycho-
logical parameters, which characterize daily distress and health-related quality of life (QoL). 
Similarly, for the caregivers, the parameters that characterize psychophysical health will be 
analyzed. These measurements are easily available and can be promptly and safely conducted 
in the hospice setting. In addition, the caregivers will complete a survey related to the DT 
intervention benefits or possible concerns.
4.2.9. Statistical analysis
SG and CG will be compared using chi-square analysis for discrete data and independent 
t-tests for continuous data on demographics and baseline variables. For each outcome 
measure (except the caregivers’ survey), the results of the DT intervention will be com-
pared by analyses of covariance (ANCOVA) taking the postintervention measurement as 
dependent values. Respective baseline value of the outcome (V1) will served as a covari-
ate. Within the statistical model, the group variable will serve as between-subject factor, 
and the postintervention measures as dependent factors. Statistical significance is set at 
the 0.05 level. The intention-to-treat principle will be used in this study. The CV transcript 
will be analyzed for content. All the statistical analyses will be conducted using the statis-
tical program.
4.2.10. Reference therapy
Usual palliative care in patients with terminal cancer includes medically indicated nonphar-
macological therapy, combined with pharmacological comfort care (e.g., pain control) and 
holistic care, focusing on management of psychophysical and spiritual needs and personal 
care (e.g., skin care). Despite that many hospice patients suffer on a daily basis from loss of 
personal autonomy, dignity, as well as mental distress, depression, and anxiety, in addition 
to physical discomfort.
Safety, potential risk of the study: No risk/adverse effects to participants have been docu-
mented with regard to the DT intervention.
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Study discontinuation: The participants may withdraw from the study due to any reason, 
without any consequences, and they will continue palliative care.
Limitations of the study: The interpretation of the results might be limited due to a small 
sample size.
Conflict of interests: There is no conflict of interests.
5. Conclusion
In summary, dignity therapy (DT) (based on research evidence from international studies, 
published in scientific literature) represents a feasible, safe, and effective, patient-friendly 
approach, targeting end-of-life psychological problems. DT has a unique potential to help 
patients with terminal stages of cancer. In particular, DT can fulfill some unmet psychological 
and spiritual needs, help preserve psychophysical integrity, and distress, as well as support 
caregivers, during the bereavement period [3, 6, 11, 13]. Since DT is unknown in Eastern and 
Central Europe, the proposed pilot study, followed by RCT, will be the first step on the way 
to explore the DT intervention in research among hospice patients in this area.
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